3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Thoracic
1
Other
1
Lymphoid
1
Gastrointestinal
1
Dermatologic
1
Conditions
Obesity
219
Neoplasms
82
Mucositis
66
Sexual Dysfunction, Physiological
65
Breast Neoplasms
64
Polycystic Ovary Syndrome
56
Overweight
55
Dyspnea
32
Motor Activity
30
Constipation
30
Head and Neck Neoplasms
28
Prostatic Neoplasms
25
Weight Loss
24
Multiple Endocrine Neoplasia Type 1
19
Colorectal Neoplasms
18
Pain
16
Diabetes Mellitus
16
Stomatitis
15
Lung Neoplasms
15
Opioid-Induced Constipation
14
Depression
14
Cardiovascular Diseases
14
Insulin Resistance
13
Endometrial Neoplasms
13
Sexuality
11
Sexual Dysfunctions, Psychological
11
Diabetes Mellitus, Type 2
11
Fatigue
10
Anxiety Disorders
10
Stomach Neoplasms
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Herpes Zoster
×
Other
×
Clear all
NCT04540081
2023-12-27
CLOVER
University of California, Davis
Phase NA
Completed
20,000 enrolled